One of the possible explanations for these results is the fact that CDKN1A alone is insufficient to stop the cell cycle and inhibit tumor cell growth, considering that mutations or loss of expression of other cell cycle/apoptosis genes such as PTEN, CDKN2A, MDM2, TP53 and RB is also associated with brain tumor etiology. Here, CDKN1A is linked to neoplasm.